Skip to content

Non-pharmacological therapy of delirium in intensive care units involving family members

Non-pharmacological therapy of delirium in intensive care units involving family members - DelFam

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00029085
Enrollment
80
Registered
2022-05-23
Start date
2022-06-26
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F05.0

Interventions

Group 1: In the intervention group, the relatives are informed about the clinical picture of delirium in a structured, standardized short instruction. The relatives are asked to carry out various non-

Sponsors

Universitätsklinikum Augsburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patient = 18 years - Presence of postoperative delirium - ICDSC >3 - Presence of legal guardianship or information according to the presumed will expressed by the relatives with subsequent establishment of guardianship - Relatives are personally and temporally able to participate in the study. - Patient is expected to remain in the intensive care unit or IMC for more than 2 days. - Informed consent is available

Exclusion criteria

Exclusion criteria: - Acute neurological or neurosurgical cerebral disease with cognitive impairment (ischemia, hemorrhage, brain tumor). - Chronic neurologic or neurosurgical cerebral disease with cognitive impairment is present (ischemia, hemorrhage, brain tumor, dementia) - patient expected to die within the next 72 h - Delirium cannot be recorded (language barrier, aphasia) - Patient who has a personal relationship to the person conducting the study - Patient who is institutionalized by court or official order - Patient who is pregnant or breastfeeding - Alcohol and/or substance intoxication/overdose or withdrawal is present

Design outcomes

Primary

MeasureTime frame
Duration of delirium during intensive or intermediate care stay.

Secondary

MeasureTime frame
Duration and dose of pharmacological measures for delirium therapy as well as duration of fixation measures, length of stay in intensive care and hospital, mortality after 28 days. In addition, it will be assessed how the relatives perceived the stay.

Countries

Germany

Contacts

Public ContactPhilipp Deetjen

Universitätsklinikum Augsburg

philipp.deetjen@uk-augsburg.de+498214002311

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026